NCT03586895 e-Connect: A Service System Intervention for Justice Youth at Risk for Suicide
| NCT ID | NCT03586895 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Columbia University |
| Condition | Suicide |
| Study Type | INTERVENTIONAL |
| Enrollment | 12,838 participants |
| Start Date | 2019-08-01 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 12,838 participants in total. It began in 2019-08-01 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators propose to create e-Connect, a new service delivery model that will enable real time identification and targeted, county-specific referral and linkage of participants with suicidal behavior (SB) and related behavioral health (BH) problems. e-Connect will: (i) establish and formalize interagency referral decisions based on clinical need, jointly derived by JJ (juvenile justice) and BH agencies; (ii) train probation staff to increase BH/SB understanding; (iii) utilize an existing evidence-based (EB) BH/SB screen; and (iv) develop a mobile application to seamlessly integrate screening, classification of clinical need and development of a related referral plan. There are 4 project phases: Development, Baseline, Implementation, and Sustainment/Evaluation. After development, activities take place in 10 NY (New York) counties and all study counties will begin the intervention at the same time. The investigators will examine changes in outcomes (e.g., service use) relative to baseline in (i) identification of participants service need (SB and BH correlates) in juvenile probationers; (ii) cross-system (probation-BH agency) referral; and (iii) participants BH service use (access and engagement). Analyses will further consider contributions of multi-level factors (e.g., staff, organizational, family, and community) that influence implementation (feasibility, acceptability, sustainability) of e-Connect across various probation department processing categories (e.g. status offenders, diversion cases). The investigators will consider the role of mediating elements (e.g., probation practices) in explaining the association between e-Connect and identification, referral, and service use.
Eligibility Criteria
Sample: County Probation Leadership (Executive and Supervisory) and Line (Juvenile Probation Officers) Staff Inclusion Criteria: Probation Officers ages 21-70 years old with active employment at the probation department working with youth, or supervise those working with youth in one of the following capacities: probation supervision, assessment, and referral, or engage in work that is related to policies, procedures, and decisions around these activities in 10 site counties Exclusion Criteria: There are no exclusionary criteria and no special classes of participants. Sample: Youth on Probation Inclusion Criteria: All new intakes ages 10-18 years old Exclusion Criteria: There are no exclusionary criteria and no special classes of participants.
Contact & Investigator
Katherine Elkington, PhD
PRINCIPAL INVESTIGATOR
Columbia University/New York State Psychiatric Institute
Frequently Asked Questions
Who can join the NCT03586895 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, studying Suicide. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03586895 currently recruiting?
Yes, NCT03586895 is actively recruiting participants. Contact the research team at ke2143@cumc.columbia.edu for enrollment information.
Where is the NCT03586895 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT03586895 clinical trial?
NCT03586895 is sponsored by Columbia University. The principal investigator is Katherine Elkington, PhD at Columbia University/New York State Psychiatric Institute. The trial plans to enroll 12,838 participants.